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Results
Background
• Sepsis is a severe and life-threatening 
condition that results from systemic 
immune dysregulation
• miR-93-5p is upregulated in early-stage 
sepsis and is proposed as a potential 
targeted therapeutic
Aims
• The luciferase assay can be used to 
evaluate miRNA binding by comparing 
florescence levels between miRNA 
knockouts and controls
Hypothesis
• We cloned a complementary miR-93-5p 
sponge construct for use with the 
luciferase assay in evaluating small 
molecule inhibitors of miR-93-5p 
function
• We also cloned luciferase constructs 
containing predicted miR-93-5p binding 




• Pilot results suggest that the luciferase assay can be used with Jurkat
suspension cells, however there are low levels of transfection across all 
cell lines which require optimization
• As expected, the Jurkat miR-93-5p knockout expressed lower levels of 
firefly luciferase activity compared to the wild-type and control lines
• Preliminary results suggest that the luciferase assay can be used to 
evaluate miR-93-5p binding using luciferase constructs, however 
additional studies are required to confirm and optimize the efficacy
Future Work
• Optimization of the transfection process using electroporation, 
lipofection, or a combination of the two
• Following colony PCR validation of the presence of the CD28 insert 
post ligation, the CD28 constructs will be sent for DNA sequencing and 
eventual transfection into the Jurkat cell lines
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Fig 1. Construct and Subcloning Design
A) Complementary miR-93-5p sponge construct
B) Schematic of the subcloning procedure for CD28 binding site inserts into the luciferase vector
A.
B.
Fig 2. Dual Luciferase Reporter Assay Results Post-Transfection with the miR-93-5p Sponge
A) Renilla/Firefly luciferase values across Jurkat cell lines. (n=3, SEM shown)
B) Average doubling time of Jurkat cells over several passages (n=6)
